Dyadic International, Inc. (DYAI)
NCM – Real Time Price. Currency in USD
0.80
+0.06 (8.10%)
At close: Jun 26, 2026, 4:00 PM EDT
0.81
+0.01 (1.12%)
After-hours: Jun 26, 2026, 6:23 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
0.80
+0.06 (8.10%)
At close: Jun 26, 2026, 4:00 PM EDT
0.81
+0.01 (1.12%)
After-hours: Jun 26, 2026, 6:23 PM EDT
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
| Name | Position |
|---|---|
| Mr. Joseph P. Hazelton | President & COO |
| Mr. Mark A. Emalfarb | Founder, CEO & Director |
| Ms. Ana Gómez Rodriguez | Secretary of the Board |
| Ms. Ping Wang Rawson CPA, M.B.A. | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-06-22 | 8-K | form8-k.htm |
| 2026-06-18 | DEFA14A | defa14a.htm |
| 2026-06-18 | 8-K | form8-k.htm |
| 2026-06-15 | 8-K | form8-k.htm |
| 2026-05-28 | 8-K | form8-k.htm |
| 2026-05-13 | 8-K | form8-k.htm |
| 2026-05-13 | 10-Q | form10-q.htm |
| 2026-05-12 | DEF 14A | formdef14a.htm |
| 2026-05-01 | PRE 14A | formpre14a.htm |
| 2026-04-30 | 10-K/A | form10-ka.htm |